Abstract
A closed form solution of the full Kermack and McKendrick integro-differential equations (Kermack and McKendrick 1927), called the KMES, is presented and verified. The solution is derived by combining network concepts with the integro-differential equations.
This solution has two parameters: one describing disease transmissibility and a second characterizing population interactions. The verified solution leads directly to useful, previously unknown, analytical expressions which characterize an epidemic. These include novel expressions for the effective reproduction number, time to peak in new infections, and the final size.
Using COVID -19 data from six countries, the transmissibility parameter is estimated and subsequently used to estimate the normalized contagiousness of an individual, a close approximation to viral shedding measured in infected persons. The population interaction parameter is estimated using the Google Residential Mobility Measure. With these parameter estimations, the KMES accurately projects case data from the COVID-19 pandemic in six countries over a 60-day period with R2 values above 0.85.
As to performance over longer periods, the KMES projects the Covid-19 total case data from the United States 21 days in advance over an 18-month period with a Mean Absolute Percentage Error of 4.1%. The KMES also accurately identifies the beginnings and peaks of outbreaks within multi month periods in case data from 4 countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: This work was funded internally by Ted Duclos Advisors and ERI.
Declarations of interest: none.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations used in this text
- KMES
- Kermack McKendrick integro-differential Equation Solution
- RCO
- Rate of Change Operator
- SIR
- Susceptible–Infectious–Recovered
- CI
- Confidence Interval